Virax Biolabs Group (VRAX) PT Lowered to $1 at H.C. Wainwright Jan 12, 2026 06:50AM
Virax Biolabs Group (VRAX) files for 25.88M share offering by selling stockholders Dec 18, 2025 04:08PM
Virax Biolabs completes UK clinical study recruitment ahead of schedule Dec 3, 2025 07:34AM
Virax Biolabs partners with Emory University for clinical studies Aug 26, 2025 07:34AM
Virax Biolabs appoints Iain Miller as independent director Jul 29, 2025 07:36AM


Mar 31, 2025 06:11AM H.C. Wainwright Starts Virax Biolabs Group (VRAX) at Buy
Mar 18, 2025 07:31AM Virax Biolabs Group (VRAX) Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
Mar 13, 2025 07:30AM Virax Biolabs Group (VRAX) Presents Data on T-Cell Dysfunction
Feb 25, 2025 07:04AM Virax Biolabs Group (VRAX) Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy
Jan 23, 2025 03:36PM Cosmos Health (COSM) Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait
Jan 23, 2025 03:35PM Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait
Jan 13, 2025 09:22AM Cosmos Health (COSM) Secures Exclusive Distribution Agreement with Virax Biolabs (VRAX) for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Coun
Jan 13, 2025 09:20AM Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries
Dec 17, 2024 07:32AM Virax Biolabs' (VRAX) CEO Issues Letter to Shareholders
Dec 10, 2024 07:32AM Virax Biolabs Group (VRAX) Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
Oct 23, 2024 07:32AM Virax Biolabs Group (VRAX) Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Sep 16, 2024 08:33AM Cosmos Health (COSM) Secures Exclusivity Agreement with Virax Biolabs (VRAX) to Distribute mpox PCR Kits across the GCC
Sep 16, 2024 08:32AM Virax Biolabs Group (VRAX) Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
Sep 16, 2024 08:30AM Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar
Aug 28, 2024 07:31AM Virax Biolabs Group (VRAX) Announces Distribution Agreement to Commercialize Mpox Virus RT-PCR Detection Kits in Europe and the Middle East
Aug 21, 2024 10:25AM Cosmos Health (COSM) Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits
Aug 21, 2024 10:20AM Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits
Aug 19, 2024 08:59AM Mpox-linked stocks extend rally into second week